XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
At The Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2021 $ 279,614 $ 9   $ 1,744,695   $ (368) $ (1,464,722)
Beginning balance (in shares) at Dec. 31, 2021   91,671          
Issuance of common stock, net of commissions and offering costs, value 20,516       $ 20,516    
Issuance of common stock, net of commissions and offering costs, shares     1,320        
RSU settlements, net of shares withheld (616)     (616)      
RSU settlements, net of shares withheld, shares   405          
Issuance of common stock pursuant to employee stock awards 96     96      
Issuance of common stock pursuant to employee stock awards, shares   10          
Stock-based compensation expense 14,335     14,335      
Net (loss) income (88,105)           (88,105)
Unrealized gain (loss) on available-for-sale securities (1,524)         (1,524)  
Ending balance at Mar. 31, 2022 224,316 $ 9   1,779,026   (1,892) (1,552,827)
Ending balance (in shares) at Mar. 31, 2022   93,406          
Beginning balance at Dec. 31, 2021 279,614 $ 9   1,744,695   (368) (1,464,722)
Beginning balance (in shares) at Dec. 31, 2021   91,671          
Net (loss) income (153,730)            
Unrealized gain (loss) on available-for-sale securities (2,591)            
Ending balance at Sep. 30, 2022 187,113 $ 9   1,808,515   (2,959) (1,618,452)
Ending balance (in shares) at Sep. 30, 2022   94,879          
Beginning balance at Mar. 31, 2022 224,316 $ 9   1,779,026   (1,892) (1,552,827)
Beginning balance (in shares) at Mar. 31, 2022   93,406          
RSU settlements, net of shares withheld (3)     (3)      
RSU settlements, net of shares withheld, shares   647          
Issuance of common stock pursuant to employee stock awards 1,309     1,309      
Issuance of common stock pursuant to employee stock awards, shares   303          
Stock-based compensation expense 14,117     14,117      
Net (loss) income 18,466           18,466
Unrealized gain (loss) on available-for-sale securities (726)         (726)  
Ending balance at Jun. 30, 2022 257,479 $ 9   1,794,449   (2,618) (1,534,361)
Ending balance (in shares) at Jun. 30, 2022   94,356          
RSU settlements, net of shares withheld (4)     (4)      
RSU settlements, net of shares withheld, shares   517          
Issuance of common stock pursuant to employee stock awards 47     47      
Issuance of common stock pursuant to employee stock awards, shares   6          
Stock-based compensation expense 14,023     14,023      
Net (loss) income (84,091)           (84,091)
Unrealized gain (loss) on available-for-sale securities (341)         (341)  
Ending balance at Sep. 30, 2022 187,113 $ 9   1,808,515   (2,959) (1,618,452)
Ending balance (in shares) at Sep. 30, 2022   94,879          
Beginning balance at Dec. 31, 2022 126,640 $ 10   1,821,721   (2,067) (1,693,024)
Beginning balance (in shares) at Dec. 31, 2022   95,927          
Issuance of common stock, net of commissions and offering costs, value 590       $ 590    
Issuance of common stock, net of commissions and offering costs, shares     148        
RSU settlements, net of shares withheld (93)     (93)      
RSU settlements, net of shares withheld, shares   463          
Stock-based compensation expense 11,764     11,764      
Net (loss) income (74,771)           (74,771)
Unrealized gain (loss) on available-for-sale securities 830         830  
Ending balance at Mar. 31, 2023 64,960 $ 10   1,833,982   (1,237) (1,767,795)
Ending balance (in shares) at Mar. 31, 2023   96,538          
Beginning balance at Dec. 31, 2022 126,640 $ 10   1,821,721   (2,067) (1,693,024)
Beginning balance (in shares) at Dec. 31, 2022   95,927          
Net (loss) income (215,676)            
Unrealized gain (loss) on available-for-sale securities 1,496            
Ending balance at Sep. 30, 2023 (50,838) $ 10   1,858,423   (571) (1,908,700)
Ending balance (in shares) at Sep. 30, 2023   101,922          
Beginning balance at Mar. 31, 2023 64,960 $ 10   1,833,982   (1,237) (1,767,795)
Beginning balance (in shares) at Mar. 31, 2023   96,538          
Exercise of pre-funded warrants   2,916          
RSU settlements, net of shares withheld (1)     (1)      
RSU settlements, net of shares withheld, shares   1,074          
Issuance of common stock pursuant to employee stock awards 747     747      
Issuance of common stock pursuant to employee stock awards, shares   574          
Stock-based compensation expense 12,552     12,552      
Net (loss) income (71,108)           (71,108)
Unrealized gain (loss) on available-for-sale securities 304         304  
Ending balance at Jun. 30, 2023 7,454 $ 10   1,847,280   (933) (1,838,903)
Ending balance (in shares) at Jun. 30, 2023   101,102          
RSU settlements, net of shares withheld, shares   820          
Stock-based compensation expense 11,143     11,143      
Net (loss) income (69,797)           (69,797)
Unrealized gain (loss) on available-for-sale securities 362         362  
Ending balance at Sep. 30, 2023 $ (50,838) $ 10   $ 1,858,423   $ (571) $ (1,908,700)
Ending balance (in shares) at Sep. 30, 2023   101,922